METABOLISM OF ELLIPTICINE AND DERIVATIVES AND ITS INVOLVEMENT IN THE ANTI-TUMOR ACTION OF THESE DRUGS

被引：30

作者：

PAOLETTI, C

LECOINTE, P

LESCA, P

CROS, S

MANSUY, D

DATXUONG, N

机构：

[1] CNRS, PHARMACOL & TOXICOL FONDAMENTALES LAB, F-31078 TOULOUSE, FRANCE

[2] ECOLE NORM SUPER, CHIM LAB, F-75231 PARIS 5, FRANCE

[3] CNRS, CHIM SUBST NAT LAB, F-91190 GIF SUR YVETTE, FRANCE

来源：

BIOCHIMIE | 1978年 / 60卷 / 09期

关键词：

D O I：

10.1016/S0300-9084(78)80587-2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1003 / 1009

页数：7

共 27 条

[1] CURE OF MICE BEARING ADVANCED PLASMA CELL TUMOURS WITH ANILINE MUSTARD - RELATIONSHIP BETWEEN GLUCURONIDASE ACTIVITY AND TUMOUR SENSITIVITY [J].

CONNORS, TA ;

WHISSON, ME .

NATURE, 1966, 210 (5038) :866-&

[2]

CONNORS TA, 1978, BIOCHIMIE, V60

[3] TOXICOLOGICAL AND PHARMACOLOGICAL STUDIES ON 9-HYDROXY-ELLIPTICINE IN MICE [J].

CROS, S ;

SORBARA, R ;

MOISAND, C ;

DATXUONG, N ;

LECOINTE, P ;

PAOLETTI, C .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1975, 33 (03) :484-497

[4] SYNTHESIS OF TUMOUR-INHIBITORY ALKALOIDS ELLIPTICINE 9-METHOXYELLIPTICINE AND RELATED PYRIDO[4,3-B]CARBAZOLES [J].

DALTON, LK ;

DEMERAC, S ;

ELMES, BC ;

LODER, JW ;

SWAN, JM ;

TEITEI, T .

AUSTRALIAN JOURNAL OF CHEMISTRY, 1967, 20 (12) :2715-&

[5]

DATXUONG N, 1975, CR ACAD SCI C CHIM, V281, P683

[6] NEW DNA INTERCALATING DRUG - METHOXY-9-ELLIPTICINE [J].

FESTY, B ;

POISSON, J ;

PAOLETTI, C .

FEBS LETTERS, 1971, 17 (02) :321-+

[7]

GOLDIN A, 1974, CANCER CHEMOTH REP 1, V58, P63

[8]

HART LB, 1967, J PHARMACOL EXP THER, V149, P7

[9]

Hartwell JL, 1969, ADV PHARMACOL CHEMOT, V7, P117, DOI 10.1016/S1054-3589(08)60561-X

[10] PRELIMINARY TRIAL OF 9-HYDROXY-2-METHYL ELLIPTICINIUM (NSC 264-137) IN ADVANCED HUMAN CANCERS [J].

JURET, P ;

TANGUY, A ;

GIRARD, A ;

LETALAER, JY ;

ABBATUCCI, JS ;

DATXUONG, N ;

LEPECQ, JB ;

PAOLETTI, C .

EUROPEAN JOURNAL OF CANCER, 1978, 14 (02) :205-206

← 1 2 3 →